¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"particle electrophoresis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diamagnetic particle
    ¹ÝÀÚ¼ºÀÔÀÚ
  • elementary particle
    ¼Ò¸³ÀÚ
  • ferromagnetic particle
    °­ÀÚ¼ºÀÔÀÚ
  • heredity particle
    À¯ÀüÀÔÀÚ
  • particle
    ÀÔÀÚ
  • particle accelerator
    ÀÔÀÚ°¡¼Ó±â
  • particle attraction
    ÀÔÀÚÀηÂ
  • particle concentration fluorescence
    ÀÔÀÚ³óÃàÇü±¤
  • particle immunoassay
    ÀÔÀڸ鿪ºÐ¼®(¹ý)
  • particle radiation
    ÀÔÀÚ¹æ»ç¼±
  • particle-enhanced turbidimetric inhibitor
    ÀÔÀÚÁõ´ëȥʾïÁ¦Á¦
  • suspended particle
    ºÎÀ¯ÀÔÀÚ, ÇöŹÀÔÀÚ, ¶áÀÔÀÚ
  • viral particle
    ¹ÙÀÌ·¯½ºÀÔÀÚ, ¹ÙÀ̸®¿Â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • charged particle radiation
    ÇÏÀüÀÔÀÚ¹æ»ç¼±
  • coarse particle
    Á¶¸³ÀÚ, °ÅÄ£ÀÔÀÚ
  • particle count
    ÀÔÀÚ°èÃø
  • defective interfering particle
    °á¼Õ°£¼·ÀÔÀÚ
  • diamagnetic particle
    ¹ÝÀÚ¼ºÀÔÀÚ
  • elementary particle
    »ý¼Ò¸³ÀÚ, ¼Ò¸³ÀÚ
  • ferromagnetic particle
    öÀÚ¼ºÀÔÀÚ
  • particle concentration fluorescence
    ÀÔÀÚ³óÃàÇü±¤
  • heredity particle
    À¯ÀüÀÔÀÚ
  • particle immunoassay
    ÀÔÀڸ鿪ºÐ¼®(¹ý)
  • particle-enhanced turbidimetric inhibitor
    ÀÔÀÚÁõ´ëȥʾïÁ¦Á¦
  • particle
    ÀÔÀÚ
  • particle radiation
    ÀÔÀÚ¼±Á¶»ç
  • particle fluence rate
    ÀÔÀÚÀ¯ÀÔ·ü
  • suspended particle
    ºÎÀ¯ÀÔÀÚ, ÇöŹÀÔÀÚ, ¶áÀÔÀÚ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • PCFIA => particle concentration fluorescence immunoassay
    ÀÔÀÚ³óÃàÇü±¤¸é¿ªÃøÁ¤(¹ý)
  • PETINIA => particle-enhanced turbidimetric inhibition immunoassay
    ÀÔÀÚÁõ´ëºñʾïÁ¦¸é¿ªÃøÁ¤(¹ý)
  • alpha particle
    ¾ËÆÄÀÔÀÚ
  • heavy charged particle
    ÁßÇÏÀüÀÔÀÚ
  • heavy particle
    ÁßÀÔÀÚ(ñìí£í­).
  • heavy particle
    ÁßÀÔÀÚ
  • heredity particle
    À¯ÀüÀÔÀÚ(ë¶îîí£í­).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • moving boundary electrophoresis
    À̵¿ÇѰèÀü±â¿µµ¿¹ý
  • moving boundary electrophoresis
    À̵¿ÇѰèÀü±â¿µµ¿(¹ý)(ì¹ÔÑùÚÍ£ï³Ñ¨ç¶ÔÑÛö) .
  • paper electrophoresis
    ¿©ÁöÀü±â¿µµ¿¹ý(æ¤òµï³Ñ¨ç¶ÔÑÛö).
  • paper electrophoresis apparatus
    ¿©ÁöÀü±â¿µµ¿ÀåÄ¡(¡­íûöÇ).
  • pulsed-field gel electrophoresis (PFGE)
    °£Çæ¾ß Àü±â¿µµ¿
  • starch block electrophoresis
    ³ì¸»ºí·ÏÀü±â¿µµ¿(¡­ï³Ñ¨ç¶ÔÑ).
  • starch gel electrophoresis
    ³ì¸»°ÖÀü±â¿µµ¿(¡­ï³Ñ¨ç¶ÔÑ).
  • zonal electrophoresis
    ´ëÀü±â¿µµ¿(¹ý)
  • zone electrophoresis
    ±¸¿ª Àü±â¿µµ¿(¹ý).
  • alpha particle
    ¾ËÆÄÀÔÀÚ
  • beta particle
    º£Å¸ÀÔÀÚ
  • charged particle
    ÇÏÀüÀÔÀÚ, ´ëÀüÀÔÀÚ
  • charged particle equilibrium
    ÇÏÀü(´ëÀü)ÀÔÀÚÆòÇü
  • charged particle radiation
    ÇÏÀü(´ëÀü)ÀÔÀÚ¹æ»ç¼±
  • coarse particle
    Á¶¸³ÀÚ, °ÅÄ£ÀÔÀÚ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • messenger ribonucleoprotein particle
    Àü·É(îîÖµ) ¸®º¸ÇÙ»ê(ß«)´Ü¹éÁú ÀÔÀÚ(Ó±ÛÜòõØ£í­)
  • particle diffusion
    ÀÔÀÚÈ®»ê(Ø£í­üªß¤)
  • particle immunoassay
    ÀÔÀÚ ¸é¿ª(Ø£í­Øóæ¹)¾Æ½êÀÌ
  • particle scattering factor
    ÀÔÀÚ »ê¶õÀÎÀÚ(Ø£í­ß¤Õ¯ì×í­)
  • particle weight
    ÀÔÀÚ·®(Ø£í­Õá)
  • PM particle
    PM ÀÔÀÚ(Ø£í­)
  • ribosomal particle
    ¶óÀ̺¸¼Ø ÀÔÀÚ(Ø£í­)
  • stripped particle
    ³ªÀÔÀÚ(Ñߨ£í­)
  • subribosomal particle
    ¾Æ(ä¬)¶óÀ̺¸¼Ø ÀÔÀÚ(Ø£í­)
  • transducing particle
    ÇüÁúµµÀÔ ÀÔÀÚ(û¡òõÓôìýØ£í­)
  • affinity electrophoresis
    ģȭÀü±â¿µµ¿ (öÑûúï³Ñ¨ç¶ÔÑ)
  • agar gel electrophoresis
    ÇÑõ(ùÎô¸)Á©Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • block electrophoresis
    ºí·Ï Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • cellulose acetate electrophoresis
    ¾Æ¼¼Æ®»ê(ß«)¼¿·ê·Î½º Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • cons electrophoresis
    "Äܽº Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ),"
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ETP electron transport particle; entire treatment period; ephedrine, theophylline, phenobarbital; eustac...
IAP immunosuppressive acidic protein; inosinic acid pyrophosphorylase; Institute of Animal Physiology; i...
IMP idiopathic myeloid proliferation; impression; incomplete male pseudohermaphroditism; individual Medi...
IPP independent practice plan; individual patient profile; inflatable penile prosthesis; inorganic pyrop...
LAI latex particle agglutination inhibition; leukocyte adherence inhibition
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
mRNP messenger ribonucleoprotein particle
PA Particle Agglutination
PCFIA Particle Concentration Fluorescence Immuno Assay
PACIA Particle Counting ImmunoAssay
PIXE Particle Induced X-ray Emission
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • particle of tissue
    Á¶Á÷Æí
  • quartz filler particle
    ¼®¿µ ÃæÀü ÀÔÀÚ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
D.I. particle <abbreviation> Defective interfering particle.
(05 Mar 2000)
dressed particle <radiobiology> A particle plus its associated neutralising Debye sphere.
(09 Oct 1997)
intramembranous particle <cell biology> Particles (or complementary pits) seen in freeze fractured membranes. The cleavage plane is through the centre of the bilayer and the particles are usually assumed to represent Integral membrane proteins (or polymers of such proteins).
(18 Nov 1997)
either particle flux density The particle fluence rate, or energy flux density, the energy fluence rate of intensity.
Compare: fluence.
(05 Mar 2000)
elementary particle interactions The interactions of particles responsible for their scattering and transformations (decays and reactions). Because of interactions, an isolated particle may decay into other particles. Two particles passing near each other may transform, perhaps into the same particles but with changed momenta (elastic scattering) or into other particles (inelastic scattering). Interactions fall into three groups: strong, electromagnetic, and weak.
(12 Dec 1998)
trapped-particle instability <radiobiology> Slowly-growing class of instabilities driven by particles which cannot circulate freely in a toroidal system.
See: banana orbit.
(09 Oct 1997)
kappa particle <microbiology> Gram-negative bacterial endosymbiont of Paramoecium spp., (Caedobacter taeniospiralis) that confers the killer trait, infected Paramoecium are resistant to the toxin liberated by infected forms. Killing activity is associated with the induction of defective phage in the endosymbiont, leading to the release of R bodies, coded for by the phage genome and apparently of mis assembled phage coat protein.
(18 Nov 1997)
Zimmermann's elementary particle <haematology> A discoid cell (3m diameter) found in large numbers in blood, important for blood coagulation and for haemostasis by repairing breaches (small breaks) in the walls of blood vessels.
Platelet _ granules contain lysosomal enzymes, dense granules contain ADP (a potent platelet aggregating factor) and serotonin (a vasoactive amine). They also release platelet-derived growth factor which presumably contributes to later repair processes by stimulating fibroblast proliferation.
Synonym: thrombocytes.
(09 Oct 1997)
agarose gel electrophoresis <procedure> A type of electrophoresis that uses a matrix of highly purified agar to separate large nucleotides in size.
(06 May 1997)
blood protein electrophoresis Electrophoresis applied to blood proteins.
(12 Dec 1998)
capillary electrophoresis A technique for separating compounds, a sample of a compound to beseparated is placed in a capillary tube, which is then subjected to ahigh voltage current that separates its chemical components.
(09 Oct 1997)
capillary zone electrophoresis A method for separating molecules extremely rapidly based on their electrophoretic mobility.
(05 Mar 2000)
gamaglobulin electrophoresis <investigation> A test that detects and measures the various immunoglobulins in the blood. In the normal assay no monoclonal antibodies are detected. In multiple myeloma and chronic lymphocytic leukaemia a single clone of lymphocytes can produce one type of immunoglobulin that is detected in the electrophoresis as monoclonal (made by one cell clone).
(27 Sep 1997)
gel electrophoresis <molecular biology> Electrophoresis using a gel supporting phase. Usually applied to systems where the gel is based on polyacrylamide.
See: electrophoresis.
(05 May 1997)
carrier electrophoresis Electrophoresis done on a carrier (such as paper, polyacrylamide gel, etc.).
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á